期刊文献+

皮肤恶性黑色素瘤组织中Runx3与Smad4蛋白的表达 被引量:1

Expressions of Runx3 and Smad4 protein in cutaneous malignant melanoma tissue
下载PDF
导出
摘要 目的:检测皮肤恶性黑色素瘤(CMM)组织中Runt相关转录因子3(Runx3)和Smad4蛋白的表达。方法:采用免疫组化SP法检测42例CMM、20例皮肤交界痣组织和20例正常皮肤组织中Runx3和Smad4蛋白的表达。结果:正常皮肤、皮肤交界痣及CMM组织中Runx3蛋白的阳性表达率分别为90.0%(18/20)、85.0%(17/20)和26.2%(11/42),3者相比,差异有统计学意义(χ2=31.371,P<0.001);正常皮肤、皮肤交界痣及CMM组织中Smad4蛋白的阳性表达率分别为85.0%(17/20)、85.0%(17/20)和42.9%(20/42),3者相比,差异有统计学意义(χ2=12.731,P=0.002)。CMM组织中Runx3和Smad4蛋白的表达存在关联性(rp=0.378,P=0.008)。结论:CMM组织中Runx3蛋白低表达或失表达,可能抑制了TGF-β/Smad4信号通路的激活,从而促进细胞的恶性转化和增殖。 Aim:To investigate the expressions of Runx3 and Smad4 protein in cutaneous malignant melanoma(CMM).Methods:The expressions of Runx3 and Smad4 protein were detected in 42 cases of CMM,20 cases of junctional nevus and 20 cases of normal skin specimens by SP immunohistochemical technique.Results: The positive expression rate of Runx3 protein in normal skin specimens, junctional nevus and CMM tissue was 90.0%(18/20),85.0%(17/20),and 26.2%(11/42),and there was significant difference(χ2=31.371,P0.001).The positive expression rate of Smad4 protein in normal skin specimens, junctional nevus and CMM tissue was 85.0%(17/20),85.0%(17/20), and 42.9%(20/42),and there was significant difference(χ2=12.731,P=0.002).The expression of Runx3 was positively associated with that of Smad4 in CMM tissue(rp=0.378,P=0.008).Conclusion:The low expression or deletion of Runx3 protein may effectively inhibit the over-activation of TGF-β/Smad4 signaling pathway, which might result in the malignant transformation and proliferation.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第6期980-983,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 皮肤恶性黑色素瘤 RUNX3 SMAD4 信号传导 cutaneous malignant melanoma Runx3 Smad4 signal transduction
  • 相关文献

参考文献7

  • 1Bangsow C, Rubins N, Glusman G, et al. The RUNX3 gene-sequence, structure and regulated expression [ J]. Gene,2001,279 ( 2 ) : 221.
  • 2Kitago M, Martinez SR, Nakamura T, et al. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma[J]. Clin Cancer Res,2009,15(9) :2 988.
  • 3Javelaud D, Alexaki VI, Mauviel A. Transforming growth factor-beta in cutaneous melanoma [ J]. Pigment Cell Melanoma Res,2008,21 (2) :123.
  • 4Zaidi SK, Sulliven A J, Wan Wijnen AJV, et al. Integration of Runx3 and Smad regulabry signals transcriptionally active subnuclear sites [ J],Proc Natl Acad Sci USA,2002, 99(12) :8 048.
  • 5Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [ J]. Science,1996,271 (5 247) :350.
  • 6Nakao A, Imamura T, Souchelnytskyi S, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4[J]. EMBO J,1997,16(17):5 353.
  • 7Zhang Y, Musci T, Derynck R. The tumor suppressor Smadd/DPC4as a central mediator of Smad fuction [ J ]. Curr Biol, 1997,7 (4) :270.

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部